INVA Q1 2020 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$79M+42.6% YoY

Gross Profit

$79M100.0% margin

Operating Income

$76M96.7% margin

Net Income

$65M83.2% margin

EPS (Diluted)

$0.59

QoQ Revenue Growth

+3.6%

Cash Flow

Operating Cash Flow

$73M

Free Cash Flow

$73M

Stock-Based Comp.

$435,000

Balance Sheet

Total Assets

$788M

Total Liabilities

$382M

Stockholders' Equity

$380M

Cash & Equivalents

$352M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$79M	$55M	+42.6%
Gross Profit	$79M	$55M	+42.6%
Operating Income	$76M	$52M	+45.9%
Net Income	$65M	$34M	+93.7%